BETHANY CUMMINGS: Open Payments
NPI 1205356870 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,087 in 63 payments from 17 companies in 2025. Trend: 2023 $598 · 2024 $482 · 2025 $1,087
Food & beverage: $912Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $194 |
| ABBVIE INC. | 20 | $186 |
| Novo Nordisk Inc | 4 | $70 |
| Abbott Laboratories | 3 | $59 |
| Lilly USA, LLC | 3 | $51 |
| Lundbeck LLC | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Corcept Therapeutics | 2 | $31 |
Products named: CAPLYTA, PROLIA, VRAYLAR, REXULTI, FREESTYLE LIBRE 3, MOUNJARO, NURTEC ODT, Korlym.
Industry payments across MS — which companies pay providers there.
